logo
Select company
Select metric
$ -1.63EBITDA per Share
VS
Market
14
Sector
37
Industry
49
History
90
$ 6.58Close
$ 6.48 - $ 42.98 52-Week Range
Ticker Information

Ticker

TVRD

Company Name

TVARDI THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TVARDI THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TVRD - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -13.45M$ -1.6318.25M
3/31/2025$ -35.47M$ -23.2711.52M
12/31/2024$ -61.83M$ -40.6611.52M
9/30/2024$ -87.17M$ -57.2211.52M
6/30/2024$ -104.48M$ -68.7311.52M
3/31/2024$ -117.75M$ -77.6511.52M
12/31/2023$ -115.58M$ -76.8411.5M
9/30/2023$ -114.69M$ -76.1311.51M
6/30/2023$ -109.94M$ -73.2911.5M
3/31/2023$ -82.69M$ -55.2611.5M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TVARDI THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -75.91.
  • Over the past 5 years, TVARDI THERAPEUTICS INC's average EBITDAPS has been $ -43.28.
  • The median EBITDAPS for TVARDI THERAPEUTICS INC during this period was $ -56.73
  • TVARDI THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ 18.05.
  • The lowest EBITDAPS recorded by TVARDI THERAPEUTICS INC in the same timeframe $ -77.65

TVARDI THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
CRBU : CARIBOU BIOSCIENCES INC $ -1.69KRRO : KORRO BIO INC $ -9.09OCGN : OCUGEN INC $ -0.17TCRX : TSCAN THERAPEUTICS INC $ -1.01LCTX : LINEAGE CELL THERAPEUTICS INC $ -0.18ACOG : ALPHA COGNITION INC $ -1.24OVID : OVID THERAPEUTICS INC $ -0.51CRVO : CERVOMED INC $ -2.53QSI : QUANTUM-SI INC $ -0.54FATE : FATE THERAPEUTICS INC $ -1.31

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for TVARDI THERAPEUTICS INC is calculated as follows: EBITDA [ $ -98.86M ] / (Shares WA [ 1.3M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -75.91 ]

TVRD - EBITDA per Share, Last 5 years

$ -77.65

Minimum

Mar 31, 2024

$ 18.05

Maximum

Sep 30, 2021

$ -43.28

Average

$ -56.73

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26